Guest: Mark S. Freedman, MSc, MD, FANA, FAAN, CSPQ, FRCPC <br>

  Guest: Ahmed Z. Obeidat, MD, PhD <br>


  
    <p>This series of bite-sized episodes contains important information on the use of high-efficacy disease-modifying therapies (DMTs) in multiple sclerosis (MS). Drs. Ahmed Obeidat and Mark Freedman discuss the role of inflammation in MS pathology, treatment strategies for high-efficacy DMTs, impact on cognition, and use in special populations. </p>

Guest: Mark S. Freedman, MSc, MD, FANA, FAAN, CSPQ, FRCPC Guest: Ahmed Z. Obeidat, MD, PhD This series of bite-sized episodes contains important information on the use of high-efficacy disease-modifying therapies (DMTs) in multiple sclerosis (MS). Drs. Ahmed Obeidat and Mark Freedman discuss the role of inflammation in MS pathology, treatment strategies for high-efficacy DMTs, impact on cognition, and use in special populations.

Share PROs in MS: A New Era of Patient-Centric Care

Sign up to save your podcasts

PROs in MS: A New Era of Patient-Centric Care

PROs in MS: A New Era of Patient-Centric Care